Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial - Concepedia

Concepedia

Publication | Closed Access

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

581

Citations

28

References

2008

Year

William J. Marks, Jill L. Ostrem, L. Verhagen, Philip A. Starr, Paul Larson, Roy A.E. Bakay, R. L. Taylor, Deborah A. Cahn‐Weiner, A. Jon Stoessl, C. Warren Olanow,

The Lancet Neurology

Neurodegenerative DiseasesIdiopathic ParkinsonMedicinePharmacotherapyNeurologyIntraputaminal DeliveryPharmacology

References

	Year	Citations

Page 1